Characterisation of the Novel HLA‐A*23:147 Allele Using New Next‐Generation Sequencing Methods
HLA · 2024
DOI: 10.1111/tan.15766 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Maëlys Giorno-Amar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunogenetics Laboratory, Etablissement français du Sang PACA Corse, Marseille, France. Hauptthemen laut MEDLINE: Alleles, High-Throughput Nucleotide Sequencing, Exons, HLA-A Antigens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐A*23:147 differs from HLA‐A*23:13 allele by one nucleotide substitution in codon 283 in exon 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunogenetics Laboratory, Etablissement français du Sang PACA Corse, Marseille, France.
- ADES UMR7268, Aix Marseille Univ, Marseille, France.
ORCID-Profile: Pascal Pedini
Zitieren
APA
Giorno-Amar, M., Avias, M., Basire, A., Frassati, C., & Pedini, P. (2024). Characterisation of the Novel HLA‐A*23:147 Allele Using New Next‐Generation Sequencing Methods. HLA. https://doi.org/10.1111/tan.15766
Vancouver
Giorno-Amar M, Avias M, Basire A, Frassati C, Pedini P. Characterisation of the Novel HLA‐A*23:147 Allele Using New Next‐Generation Sequencing Methods. HLA. 2024. doi:10.1111/tan.15766
BibTeX
@article{GiornoAmar2024,
author = {Giorno-Amar, Maëlys and Avias, Maude and Basire, Agnès and Frassati, Coralie and Pedini, Pascal},
title = {Characterisation of the Novel HLA‐A*23:147 Allele Using New Next‐Generation Sequencing Methods},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15766}
}
EUVIMED